A PHASE-I PHASE-II SECSG (SOUTHEASTERN-CANCER-STUDY-GROUP) PILOT-STUDY OF SURGICAL ADJUVANT IMMUNOTHERAPY WITH VACCINIA MELANOMA ONCOLYSATES (VMO)

被引:0
作者
WALLACK, MK
MCNALLY, K
MICHAELIDES, M
BASH, J
BARTOLUCCI, A
SIEGLER, H
BALCH, C
WANEBO, H
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:148 / 151
页数:4
相关论文
共 15 条
[1]  
CASSEL WA, CANCER
[2]  
GRANT RM, 1974, LANCET, P1096
[3]   IMMUNOTHERAPY OF OSTEOSARCOMA PATIENTS WITH VIRUS-MODIFIED TUMOR-CELLS [J].
GREEN, AA ;
PRATT, C ;
WEBSTER, RG ;
SMITH, K .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 277 (SEP20) :396-411
[4]  
LINDENMANN J, 1974, BIOCHIM BIOPHYS ACTA, V335, P49
[5]  
MURRAY DR, 1977, CANCER, V40, P680, DOI 10.1002/1097-0142(197708)40:2<680::AID-CNCR2820400214>3.0.CO
[6]  
2-#
[7]  
PRAGER MD, 1973, METHOD CANCER RES, P339
[8]  
SAUTER C, 1978, IMMUNOTHERAPY CANCER, P355
[9]  
Scott M T, 1974, Semin Oncol, V1, P367
[10]  
SHARPLESS GR, 1950, P SOC EXP BIOL MED, V73, P270, DOI 10.3181/00379727-73-17651